解郁1号方对卒中后大鼠脑内神经递质及海马组织Notch信号通路的影响

赵娜, 吴旭杰, 朱政羽, 林书阳, 胡万华

中国药学杂志 ›› 2020, Vol. 55 ›› Issue (13) : 1072-1077.

PDF(4165 KB)
PDF(4165 KB)
中国药学杂志 ›› 2020, Vol. 55 ›› Issue (13) : 1072-1077. DOI: 10.11669/cpj.2020.13.004
论著

解郁1号方对卒中后大鼠脑内神经递质及海马组织Notch信号通路的影响

  • 赵娜, 吴旭杰, 朱政羽, 林书阳, 胡万华*
作者信息 +

Effect of Jieyu No.1 Recipe on Neurotransmitter and Notch Signaling Pathway in Hippocampus of Rats After Stroke

  • ZHAO Na, WU Xu-jie, ZHU Zheng-yu, LIN Shu-yang, HU Wan-hua*
Author information +
文章历史 +

摘要

目的 分析解郁1号方对卒中后抑郁(PSD)大鼠行为学、脑内神经递质及海马组织Notch信号通路的影响。方法 选取SPF级Wistar雄性大鼠60只,随机数字表法将大鼠分成4组,除正常组外,其他各组大鼠制备PSD模型,成功造模后阳性对照组大鼠灌胃2.33 mg·kg-1的盐酸氟西汀药液,解郁1号方组灌胃2 g·kg-1的解郁1号方药液,正常组和模型组大鼠灌胃等剂量蒸馏水,1次·d-1,连续灌胃8周。观察各组大鼠行为学表征、脑组织内神经递质含量、Notch蛋白、Hes蛋白表达和Notch1、Hes1 mRNA表达,并检测各组大鼠海马组织内Notch信号路径功能情况。结果 和正常组相比,给药后1、4、8周模型组大鼠神经功能评分升高;和模型组相比,给药后1、4、8周阳性对照组、解郁1号方组大鼠神经功能评分降低,差异有统计学意义(P<0.05);和正常组相比,模型组大鼠垂直运动、水平运动、清洁动作次数降低,粪便数、中央格停留时间升高;和模型组相比,阳性对照组、解郁1号方组大鼠垂直运动、水平运动、清洁动作次数升高,粪便数、中央格停留时间降低,差异有统计学意义(P<0.05);和正常组相比,模型组大鼠脑组织内5-羟吲哚乙酸(5-HIAA)、去甲肾上腺素(NE)、5-羟色氨酸(5-HT)及多巴胺(DA)含量降低;和模型组相比,阳性对照组、解郁1号方组大鼠脑组织内5-HIAA、NE、5-HT及DA含量升高,差异有统计学意义(P<0.05);和正常组相比,模型组大鼠开放时间、电流幅度、开放概率升高,关闭时间降低;和模型组相比,阳性对照组、解郁1号方组大鼠开放时间、电流幅度、开放概率升高,关闭时间降低,差异有统计学意义(P<0.05)。结论 解郁1号方可提升PSD大鼠脑组织内神经递质含量,改善行为学表现,其作用机制可能和激活大鼠海马组织内Notch信号通路有关,从而加速神经功能的恢复。

Abstract

OBJECTIVE To analyze the effects of Jieyu No.1(traditional Chinese medicine) on behavior, brain neurotransmitter and hippocampus Notch signaling pathway in post-stroke depression (PSD) rats. METHODS Sixty Wistar male rats of SPF grade were randomly divided into four groups. The PSD model was prepared by rats in other groups except the normal group. After successful modeling, the rats in the positive control group were intragastrically administered 2.33 mg·kg-1 of fluoxetine hydrochloride solution, Jieyu No.1 prescription group 2 g·kg-1 of Jieyu No.1 prescription liquid, rats in normal group and model group were given equal dose of distilled water, once/d, continuous irrigation Stomach for 8 weeks. The behavioral characterization, neurotransmitter content, Notch protein, Hes protein expression and Notch1 and Hes1 mRNA expression in the brain of each group were observed. The function of Notch signal pathway in hippocampus of each group was detected. RESULTS Compared with the normal group, the neurological function scores of the model group increased at 1, 4, and 8 weeks after administration; compared with the model group, the positive control group and the Jieyu 1 group were administered 1, 4, and 8 weeks after administration. The neurological function score of rats was decreased, and the difference was statistically significant (P<0.05). Compared with the normal group, the vertical movement, horizontal movement, and cleaning movements of the model group decreased, and the number of feces and the residence time of the central compartment increased. Compared with the model group, the positive control group and the Jieyu 1 group were larger. The vertical movement, horizontal movement, and cleaning movements of the rats increased, the number of stools and the residence time of the central compartment decreased, and the difference was statistically significant (P<0.05). Compared with the normal group, the 5-HIAA in the brain tissue of the model group was the contents of NE, 5-HT and DA were decreased. Compared with the model group, the contents of 5-HIAA, NE, 5-HT and DA in the brain of rats in the positive control group and Jieyu No.1 group were increased. The difference was statistically significant(P<0.05); compared with the normal group, the model group rats increased open time, current amplitude, open probability, and closed time decreased; compared with the model group, positive control group, Jieyu 1 square group rats open time, flow amplitude, open probability increased, reducing the off-time, the difference was statistically significant (P<0.05). CONCLUSION Jieyu No.1 can increase the neurotransmitter content in the brain tissue of PSD rats and improve the behavioral behavior. The mechanism may be related to the activation of Notch signaling pathway in rat hippocampus, thus accelerating the recovery of nerve function.

关键词

卒中后抑郁 / Notch信号通路 / 神经递质 / 解郁1号方

Key words

post-stroke depression / Notch signaling pathway / neurotransmitter / Jieyu No. 1

引用本文

导出引用
赵娜, 吴旭杰, 朱政羽, 林书阳, 胡万华. 解郁1号方对卒中后大鼠脑内神经递质及海马组织Notch信号通路的影响[J]. 中国药学杂志, 2020, 55(13): 1072-1077 https://doi.org/10.11669/cpj.2020.13.004
ZHAO Na, WU Xu-jie, ZHU Zheng-yu, LIN Shu-yang, HU Wan-hua. Effect of Jieyu No.1 Recipe on Neurotransmitter and Notch Signaling Pathway in Hippocampus of Rats After Stroke[J]. Chinese Pharmaceutical Journal, 2020, 55(13): 1072-1077 https://doi.org/10.11669/cpj.2020.13.004
中图分类号: R965   

参考文献

[1] VOLZ M, MÖBUS J, LETSCH C, et al. The influence of early depressive symptoms, social support and decreasing self-efficacy on depression 6 months post-stroke[J]. J Affect Disord, 2016, 206(34):252-255.
[2] OUCHI Y, BANNO Y, SHIMIZU Y, et al. Reduced adult hippocampal neurogenesis and working memory deficits in the Dgcr8-deficient mouse model of 22q11.2 deletion-associated schizophrenia can be rescued by IGF2[J]. J Neurosci, 2013, 33(22):9408-9419.
[3] MENG G, MA X, LI L, et al. Predictors of early-onset post-ischemic stroke depression:a cross-sectional study[J]. BMC Neurol, 2017, 17(1):199-202.
[4] CHENG Y, GAO X H, LI X J, et al. Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway[J]. Oncogene, 2018, 37(22):2953-2966.
[5] WANG Q, YOU F Q, XIONG J, et al. Advances in the establishment and evaluation of rodent models of post-stroke depression[J]. Chin J Rehabil Med, 2014, 29(12):1196-1199.
[6] CHEN J X, LI W, ZHAO Q, et al. Effects of three traditional Chinese herbal compounds on BDNF and TrkB in cortex and hippocampus of rats with chronic restraint stress[J]. Chin J Pathophysiol(中国病理生理杂志), 2007, 23(7):1296-1300.
[7] FENG R, WANG P, GAO C, et al. Effect of sertraline in the treatment and prevention of poststroke depression: a Meta-analysis[J]. Medicine, 2018, 97(49):e13453.
[8] DEYAMA S, ISHIKAWA Y, YOSHIKAWA K, et al. Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway[J]. Int J Neuropsychopharmacol, 2017, 20(7):575-584.
[9] BUGA A M, SURUGIU R, DUMBRAVA D, et al. The impact of aging on post-stroke depression[J]. Exp Gerontol, 2017, 94(23):112-113.
[10] XIE W J, DONG M, LIU Q, et al. Early predictors and prevention for post-stroke epilepsy:changes in neurotransmitter levels[J]. Transl Neurosci, 2016, 7(1):1-5.
[11] JIANG S H, LI J, DONG F Y, et al. Increased serotonin signaling contributes to the warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice[J]. Gastroenterology, 2017, 153(1):277-291.
[12] AMP L W, WILKINS. Correction to:in-hospital risk prediction for post-stroke depression:development and validation of the post-stroke depression prediction scale[J]. Stroke, 2017, 48(6):e151-e151.
[13] SARFO F S, JENKINS C, SINGH A, et al. Post-stroke depression in ghana:characteristics and correlates[J]. J Neurol Sci, 2017, 379(15):261-265.
[14] WANG S B, WANG Y Y, ZHANG Q E, et al. Cognitive behavioral therapy for post-stroke depression: a Meta-analysis[J]. J Affect Disord, 2018, 235(17):589-596.
[15] MIRANDA J J, MOSCOSO M G, TOYAMA M, et al. Role of mHealth in overcoming the occurrence of post-stroke depression[J]. Acta Neurol Scand, 2017, 137(4):12-19.

基金

浙江省中医药科学研究基金项目资助(2017ZB087)
PDF(4165 KB)

Accesses

Citation

Detail

段落导航
相关文章

/